Investegate | Company Announcement

Investegate announcements from Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

Related Keywords

France , Paris , France General , Belgium , Saclay , China , Italy , Cambridge , Cambridgeshire , United Kingdom , Shanghai , United States , Germany , America , American , Asia Pacific , Ipsen Euronext , Christelle Huguet , Jennifer Moore , Amy Wolf , Ioana Piscociu , Nicolas Bogler , European Medicines Agency , Albireo Pharma Inc , European Society For Pediatric Gastroenterology Hepatology , Committee For Medicinal Products Human , Development For Ipsen , Head Of Research , Committee For Orphan Medicinal Products , Global Corporate Communications , Committee For Medicinal Products Human Use , Head Of Corporate Brand Strategy Communications , Authorisation Application , Medicinal Products , Human Use , Orphan Medicinal Products , Marketing Authorisation Application , Executive Vice President , Orphan Medicinal Product Regulation , Pediatric Gastroenterology Hepatology , North America , Middle East , Reported Outcome , Safety Information , Test Abnormalities , Soluble Vitamin , Rare Disease , Sponsored Level , American Depositary Receipt , Investor Relations , Relations Manager , Corporate Brand Strategy , Global Media Relations , French Autorit , Des March , Universal Registration Document , Announcements , Nvestegate Alerts , K Wire , Uk News , Ews Alerts , Mail News Alerts , Tse News Alerts , Tse Email Alerts , Echmark Announcements , Tse , Regulatory News , Ns Announcements , Quities , Quity News , Quity Announcements , Company News , Hares , Corporate News , Orporate Financial News , Orporate News Releases , Orporate Finance News , Usiness News ,